scholarly article | Q13442814 |
P2093 | author name string | Koopman JS | |
Jacobsen KH | |||
P2860 | cites work | A survey on hepatitis A in Portuguese children and adolescents. | Q43338911 |
Hepatitis A seroprevalence rate in Syria | Q43340067 | ||
The prevalence of antibody to hepatitis A virus in Singapore | Q43514300 | ||
Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey | Q43674686 | ||
Hepatitis A virus antibodies in Belgium: relationship between prevalence and age. | Q44019728 | ||
Prevalence of hepatitis A antibodies in southeastern Spain: a population-based study | Q44316383 | ||
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation | Q44388264 | ||
Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. | Q44560831 | ||
Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy | Q44753531 | ||
Childhood epidemiology of hepatitis A virus in Riyadh, Saudi Arabia | Q45406500 | ||
Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination | Q45723040 | ||
Assessing hepatitis A virus epidemic stochastic process in eight cities in China in 1990. | Q45755942 | ||
Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain | Q45772142 | ||
Prevalence of antibody to hepatitis A virus among children in Trabzon, Turkey | Q45775303 | ||
Racial differences in the seroprevalence of hepatitis A virus infection in Natal/KwaZulu, South Africa | Q45784932 | ||
Hepatitis A virus infection in households | Q45792939 | ||
Prevalence of antibody to hepatitis A virus in Okinawa and Kyushu, Japan | Q45799013 | ||
A seroepidemiologic study of hepatitis A virus infections: statistical analysis of two independent cross-sectional surveys in Okinawa, Japan | Q45831222 | ||
Hepatitis B virus infection in children in Sardinia, Italy | Q45843198 | ||
Age-specific prevalence of hepatitis A virus antibody in Ethiopian children | Q45849113 | ||
Changing patterns of hepatitis A virus infection in children in Palermo, Italy | Q45849225 | ||
Declining prevalence of antibodies to hepatitis: A virus infection in iceland | Q45863698 | ||
Early asymptomatic hepatitis A in Senegalese children | Q46929802 | ||
A model of long-term decline in the transmissibility of an infectious disease: implications for the incidence of hepatitis A. | Q50194724 | ||
Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. | Q50906394 | ||
Hepatitis A immunity in the Swedish population. A study of the prevalence of markers in the Swedish population. | Q53984237 | ||
A ten year serological survey of hepatitis A, B and C viruses infections in Nepal. | Q55240047 | ||
The intensity of transmission of hepatitis A and heterogeneities in socio-environmental risk factors in Rio de Janeiro, Brazil | Q57166871 | ||
Current seroepidemiology of hepatitis A in Hong Kong | Q58236472 | ||
Declining hepatitis A seroprevalence: a global review and analysis. | Q36001458 | ||
Age-specific antibody prevalence to hepatitis A in England: implications for disease control | Q36503452 | ||
Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain | Q36504318 | ||
Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups | Q36523327 | ||
Seroprevalence of viral hepatitis A in the Czech Republic | Q38466425 | ||
Antibody against hepatitis A in Saudi Arabians and in expatriates from various parts of the world working in Saudi Arabia | Q39190704 | ||
Hepatitis A shifting epidemiology in the Middle East and Africa | Q39192407 | ||
Studies on antibody to hepatitis A virus in children and adults in London | Q39205709 | ||
Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markers | Q39339695 | ||
The changing epidemiologic pattern of hepatitis A infection in urban Greece | Q39339724 | ||
Age-specific prevalence of hepatitis A virus antibody in Thailand | Q39341827 | ||
Hepatitis A and hepatitis B virus infection in children and adolescents in north-east Italy | Q39349463 | ||
Prevalence of antibody to hepatitis A in Iceland in relation to age, sex, and number of notified cases of hepatitis | Q39359693 | ||
Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community | Q39367205 | ||
Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers, in Goiania, Brazil | Q39374665 | ||
Decline in anti-HAV prevalence in the Milan area between 1958 and 1992. | Q39386401 | ||
Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain). | Q39417743 | ||
Hepatitis A incidence rate estimates from a pilot seroprevalence survey in Rio de Janeiro, Brazil. | Q39517399 | ||
Prevalence of anti-hepatitis A antibodies in an urban middle class area of Argentina: some associated factors | Q39529783 | ||
Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). | Q39573621 | ||
The epidemiology of hepatitis A in Rio de Janeiro: environmental and domestic risk factors | Q39584931 | ||
Preliminary Serologic Studies of Antibody to Hepatitis A Virus in Populations in the United States | Q40027647 | ||
The Changed Epidemiology of Hepatitis A Infection in Scandinavia | Q40162730 | ||
Decrease in incidence of hepatitis a infections in Germany | Q40198163 | ||
Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys | Q40717078 | ||
The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey | Q40748632 | ||
The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea | Q40772354 | ||
Population-based survey of hepatitis A virus infection in the Republic of San Marino | Q40879842 | ||
Epidemiology of hepatitis A in Valencia, Spain: public health implications. | Q41007986 | ||
IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study | Q41468038 | ||
Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland | Q42984845 | ||
Hepatitis A, B and C seroprevalence in Pakistan | Q43036975 | ||
Epidemiology of hepatitis A in Mediterranean countries | Q43309783 | ||
Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors | Q43333584 | ||
P433 | issue | 3 | |
P921 | main subject | socioeconomics | Q1643441 |
seroprevalence | Q3511357 | ||
Hepatitis A virus | Q4112120 | ||
hepatitis A | Q157661 | ||
P304 | page(s) | 600-609 | |
P577 | publication date | 2005-04-14 | |
P1433 | published in | International Journal of Epidemiology | Q6051393 |
P1476 | title | The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns | |
P478 | volume | 34 |
Q81572029 | A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China |
Q38252498 | A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region |
Q33541273 | A review of data needed to parameterize a dynamic model of measles in developing countries |
Q40044938 | A statistical model to estimate the impact of a hepatitis A vaccination programme |
Q37421432 | Age-period-cohort analysis of hepatitis A incidence rates in Korea from 2002 to 2012. |
Q36075046 | Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review |
Q35465620 | Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia |
Q34757384 | Basic mathematical models for the temporal dynamics of HAV in medium-endemicity Italian areas |
Q35533510 | Challenges to mapping the health risk of hepatitis A virus infection |
Q35993848 | Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults |
Q39628691 | Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka |
Q33265523 | Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A. |
Q37394565 | Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh |
Q57385730 | Comparative hepatitis A seroepidemiology in 10 European countries |
Q43807408 | Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment? |
Q35093540 | Decreasing risk of hepatitis A infection in León, Nicaragua: evidence from cross-sectional and longitudinal seroepidemiology studies |
Q37002452 | Detection and Molecular Characterization of Hepatitis A Virus from Tunisian Wastewater Treatment Plants with Different Secondary Treatments. |
Q58130211 | Do medical college students living in hostel in India need hepatitis A vaccine? |
Q26784450 | Epidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol |
Q41125396 | Estimating the critical immunity threshold for preventing hepatitis A outbreaks in men who have sex with men. |
Q33933442 | Evidence of hepatitis A virus person-to-person transmission in household outbreaks. |
Q40347139 | Fecal‐Orally Transmitted Diseases Among Travelers Are Decreasing Due to Better Hygienic Standards at Travel Destination |
Q54263022 | Globalization and the Changing Epidemiology of Hepatitis A Virus. |
Q33553107 | Hepatitis A among refugees, asylum seekers and migrants living in hosting facilities, Greece, April to December 2016. |
Q63245087 | Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis |
Q82218124 | Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine |
Q34989500 | Hepatitis A surveillance and vaccine use in China from 1990 through 2007 |
Q36970157 | Hepatitis A vaccination in developing countries: Is Syria next? |
Q34013577 | Hepatitis A virus in West Africa: Is an epidemiological transition beginning? |
Q38231524 | Hepatitis A virus in the Middle East and North Africa region: a new challenge |
Q34132177 | Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. |
Q93046069 | Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015 |
Q37337759 | Hepatitis a virus seropositivity in nurses and paramedical personnel at a university hospital in north iran. |
Q33603873 | High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo |
Q35230459 | High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran |
Q43353874 | High prevalence of anti-hepatitis A virus immunoglobulin G antibody among healthcare facility attendees in Osogbo, Nigeria |
Q85064985 | Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1-16 years |
Q33619565 | Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay |
Q36175752 | Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review |
Q42224674 | Incidence and molecular characterization of hepatitis A viruses in Korean surface water between 2007 and 2010. |
Q26866356 | Live attenuated hepatitis A vaccines developed in China |
Q44756993 | Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004. |
Q44789022 | Mathematical modeling and the epidemiological research process |
Q38933049 | Modeling the hepatitis A epidemiological transition in Thailand |
Q35138754 | Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus |
Q34308655 | Pattern of hepatitis a incidence according to area characteristics using national health insurance data |
Q37356170 | Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina |
Q40056662 | Prevalence of G6PD deficiency in Children with Hepatitis A. |
Q42287066 | Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany |
Q40124975 | Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study |
Q52668904 | Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach. |
Q38617154 | Quantifying the population effects of vaccination and migration on hepatitis A seroepidemiology in Australia. |
Q36917182 | Risk factors for acute hepatitis A infection in Korea in 2007 and 2009: a case-control study |
Q90435614 | Risk factors for viral hepatitis A infection in Gampaha District, Sri Lanka: an unmatched case control study |
Q37083095 | Seroepidemiology of hepatitis a infection in northeastern china, Korea, and Japan |
Q39834918 | Seroprevalence of hepatitis A virus among Iranian soldiers |
Q36412278 | Seroprevalence of hepatitis a and associated factors among 1-15 year old children in Eastern Turkey |
Q34725927 | Seroprevalence of hepatitis a and associated socioeconomic factors in young healthy korean adults |
Q43344549 | Shifting seroepidemiology of hepatitis A in Japan, 1973-2003. |
Q37703292 | Spatial analysis of the home addresses of hospital patients with hepatitis B infection or hepatoma in Shenzhen, China from 2010 to 2012 |
Q33833205 | Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran |
Q45336096 | The Syrian refugees crisis brings challenges to the health authorities in Europe: hepatitis A virus is a case in point |
Q33321690 | The United States and Canada as a coupled epidemiological system: an example from hepatitis A |
Q34132167 | The costs of hepatitis A infections in South Korea. |
Q47160922 | The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015. |
Q93038262 | The global epidemiology of viral-induced acute liver failure: a systematic review protocol |
Q45384697 | The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies. |
Q40051750 | The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited |
Q64923093 | The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence. |
Q44038112 | Use of a catalytic model to estimate hepatitis A incidence in a low-endemicity country: implications for modeling immunization policies |
Search more.